AERIE PHARMACEUTICALS INC (AERI)
US00771V1089 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 54.09M | 37.19M | 151.60M | 143.90M | 202.80M | |||
| Marketable Securities | 118.37M | 102.61M | 88.80M | 165.30M | 0.00 | |||
| Receivables | 73.88M | 158.83M | 56.00M | 38.40M | 2.70M | |||
| Inventories | 46.76M | 40.41M | 27.10M | 21.10M | 10.10M | |||
| Other Current Assets | 9.71M | 16.61M | 8.30M | 7.70M | 4.50M | |||
| Total Current Assets | 302.81M | 355.65M | 331.80M | 376.30M | 220.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 71.06M | 74.14M | 68.30M | 74.70M | 60.50M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.72M | 1.60M | 1.90M | 1.60M | 4.30M | |||
| Total Non-Current Assets | 72.78M | 75.74M | 70.20M | 76.30M | 64.80M | |||
| TOTAL ASSETS | 375.59M | 431.39M | 402.00M | 452.60M | 285.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 124.27M | 116.71M | 95.60M | 70.90M | 38.40M | |||
| Accounts Payable | 9.06M | 8.29M | 8.80M | 12.80M | 12.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 133.33M | 124.99M | 104.50M | 83.60M | 50.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 312.59M | 234.53M | 210.40M | 188.70M | 0.00 | |||
| Other Non-Current Liabilities | 93.65M | 89.21M | 63.20M | 13.40M | 6.50M | |||
| Total Non-Current Liabilities | 406.24M | 323.73M | 273.60M | 202.10M | 6.40M | |||
| TOTAL LIABILITIES | 539.57M | 448.72M | 378.10M | 285.70M | 57.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.19B | -1.15B | -1.08B | -896.00M | -696.40M | |||
| Additional Paid In Capital | 1.02B | 1.14B | 1.10B | 1.06B | 924.20M | |||
| Common Shares | 49.00K | 48.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -803.00K | -126.00K | -100.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 49.39M | 48.44M | 46.80M | 46.50M | 45.50M | |||
| Tangible Book Value per Share | -3.32 | -0.36 | 0.51 | 3.59 | 5.01 | |||
| Total Shareholders' Equity | -163.98M | -17.33M | 24.00M | 167.00M | 227.80M | |||
| TOTAL LIABILITIES AND EQUITY | 375.59M | 431.39M | 402.00M | 452.60M | 285.00M | |||
| Statistics | ||||||||
| Debt/Equity | -1.91 | -13.53 | 8.77 | 1.13 | N/A | |||
| Current Ratio | 2.27 | 2.85 | 3.18 | 4.50 | 4.33 | |||
| Return On Assets (ROA) | -9.73% | -17.34% | -45.55% | -44.10% | -81.60% | |||
| Return On Equity (ROE) | N/A | N/A | -762.92% | -119.51% | -102.09% | |||
All data in USD